BindingDB logo
myBDB logout

BDBM50117584 1-Benzyl-4-[3-(2,3-dihydro-benzofuran-5-yl)-3-oxo-propyl]-1-methyl-piperidinium::CHEMBL87344

SMILES: C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3OCCc3c2)CC1

InChI Key: InChIKey=XHKYPQJDZKCEOF-UHFFFAOYSA-N

Data: 1 IC50  1 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50117584   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Acetylcholinesterase


(Homo sapiens (Human))
BDBM50117584
PNG
(1-Benzyl-4-[3-(2,3-dihydro-benzofuran-5-yl)-3-oxo-...)
Show SMILES C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3OCCc3c2)CC1 |(20.14,-5.28,;19.05,-6.38,;20.38,-7.15,;21.72,-6.38,;21.71,-4.84,;23.04,-4.07,;24.38,-4.84,;24.38,-6.38,;23.05,-7.15,;19.05,-4.84,;17.74,-4.07,;16.4,-4.83,;15.14,-4.18,;13.73,-4.81,;12.48,-3.9,;12.65,-2.36,;11.07,-4.53,;10.92,-6.05,;9.52,-6.68,;8.24,-5.79,;6.73,-6.1,;5.96,-4.74,;7.01,-3.59,;8.43,-4.25,;9.83,-3.62,;16.39,-6.37,;17.72,-7.15,)|
Show InChI InChI=1S/C24H30NO2/c1-25(18-20-5-3-2-4-6-20)14-11-19(12-15-25)7-9-23(26)21-8-10-24-22(17-21)13-16-27-24/h2-6,8,10,17,19H,7,9,11-16,18H2,1H3/q+1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 17n/an/an/an/an/an/a



Organon Laboratories Ltd.

Curated by ChEMBL


Assay Description
In vitro reversal of vecuronium-induced neuromuscular block in guinea pig hemi-diaphragm.


Bioorg Med Chem Lett 12: 2565-8 (2002)


BindingDB Entry DOI: 10.7270/Q2CZ37Q4
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))
BDBM50117584
PNG
(1-Benzyl-4-[3-(2,3-dihydro-benzofuran-5-yl)-3-oxo-...)
Show SMILES C[N+]1(Cc2ccccc2)CCC(CCC(=O)c2ccc3OCCc3c2)CC1 |(20.14,-5.28,;19.05,-6.38,;20.38,-7.15,;21.72,-6.38,;21.71,-4.84,;23.04,-4.07,;24.38,-4.84,;24.38,-6.38,;23.05,-7.15,;19.05,-4.84,;17.74,-4.07,;16.4,-4.83,;15.14,-4.18,;13.73,-4.81,;12.48,-3.9,;12.65,-2.36,;11.07,-4.53,;10.92,-6.05,;9.52,-6.68,;8.24,-5.79,;6.73,-6.1,;5.96,-4.74,;7.01,-3.59,;8.43,-4.25,;9.83,-3.62,;16.39,-6.37,;17.72,-7.15,)|
Show InChI InChI=1S/C24H30NO2/c1-25(18-20-5-3-2-4-6-20)14-11-19(12-15-25)7-9-23(26)21-8-10-24-22(17-21)13-16-27-24/h2-6,8,10,17,19H,7,9,11-16,18H2,1H3/q+1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/an/an/a 90n/an/an/an/a



Organon Laboratories Ltd.

Curated by ChEMBL


Assay Description
In vitro reversal of vecuronium-induced neuromuscular block in guinea pig hemi-diaphragm.


Bioorg Med Chem Lett 12: 2565-8 (2002)


BindingDB Entry DOI: 10.7270/Q2CZ37Q4
More data for this
Ligand-Target Pair